Old Web
English
Sign In
Acemap
>
Paper
>
Long-Term 3-Year Efficacy of Dupilumab in QUEST Patients Enrolled in LIBERTY ASTHMA TRAVERSE
Long-Term 3-Year Efficacy of Dupilumab in QUEST Patients Enrolled in LIBERTY ASTHMA TRAVERSE
2021
Alberto Papi
Arnaud Bourdin
Henrik Watz
Ian D. Pavord
Christian Domingo
Michael E. Wechsler
X. Mao
Benjamin Ortiz
M. Djandji
L.P. Mannent
Marcella Ruddy
E. Laws
Nikhil Amin
David Lederer
M Hardin
Keywords:
Term (time)
Traverse
Pediatrics
Asthma
Dupilumab
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]